---
title: "Prenatal Alcohol and Smoking Patterns Linked to Maternal Depression and Anxiety Across the Perinat"
id: "medrxiv-8-patterns-of-substance-use-during-pregnancy-are-differentially-associated-with"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-8-patterns-of-substance-use-during-pregnancy-are-differentially-associated-with"
content_type: "clinical_feed_article"
specialty: "General"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.10.01.26364530v1?rss=1"
published_at: "2026-10-05T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Prenatal Alcohol and Smoking Patterns Linked to Maternal Depression and Anxiety Across the Perinat
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-8-patterns-of-substance-use-during-pregnancy-are-differentially-associated-with
- **Specialty:** [General](https://medichelpline.com/clinical-feed/general.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.10.01.26364530v1?rss=1)
- **Published At:** 2026-10-05T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This prospective analysis used data from the Avon Longitudinal Study of Parents and Children (ALSPAC) to examine how longitudinal patterns of **alcohol** and **cigarette** use across pregnancy relate to maternal depressive and anxiety symptoms from the second trimester through 21 months postpartum. - Substance use was modeled as four longitudinal patterns per exposure: **abstained**, **persistent**, **intermittent**, and **discontinued**. - Maternal depressive and anxiety symptoms were measured using the Crown-Crisp Experiential Index at multiple time points spanning pregnancy and the first two years postpartum. - Persistent prenatal **alcohol** use was associated with higher levels of depressive and anxiety symptoms and with a slower decline in symptoms over time compared with abstainers. - For prenatal **smoking**, persistent, intermittent, and quitting (discontinued) patterns were each associated with higher overall symptom levels relative to abstainers; persistent smoking additionally showed steeper declines in symptoms over time. - Intermittent or discontinued alcohol use had symptom profiles similar to abstainers, suggesting that persistence of alcohol use during pregnancy may be a key marker of increased perinatal psychological distress. - The authors highlight that differentiating patterns of substance use—especially persistent use—could improve screening and early intervention to identify women at elevated risk for perinatal mental health problems. - The study is a preprint and has not been peer reviewed; ethical approvals and consents were obtained through ALSPAC committees and secondary analyses were approved by Mass General Brigham IRB. - Data are available by request from ALSPAC; funding sources include NIH grants and the MQ Foundation. These findings should not be used to guide clinical practice until peer review.
## Clinical Analysis & Structured Key Points
Patterns of substance use during pregnancy are differentially associated with maternal mental health across the perinatal period | medRxiv Skip to main content Patterns of substance use during pregnancy are differentially associated with maternal mental health across the perinatal period Kimberly N Palmer , Ka Ying Toby Law , Suena H Massey , View ORCID Profile Alexandre A Lussier doi: https://doi.org/10.64898/2026.10.01.26364530 Kimberly N Palmer 1 Massachusetts General Hospital; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Ka Ying Toby Law 2 McLean Hospital Find this author on Google Scholar Find this author on PubMed Search for this author on this site Suena H Massey 1 Massachusetts General Hospital; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Alexandre A Lussier 2 McLean Hospital Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Alexandre A Lussier For correspondence: alussier{at}mclean.harvard.edu Abstract Info/History Metrics Supplementary material Data/Code Preview PDF Abstract Background: Substance use during pregnancy can substantially increase risk for postpartum depression and anxiety symptoms, which can have lasting effects on family functioning and child development. However, substance use is often conceptualized as a binary exposure, limiting our understanding of whether specific patterns of use are associated with maternal mental health in the perinatal period. Here, we examined longitudinal patterns of prenatal alcohol use and smoking in relation to maternal depressive and anxiety symptoms across pregnancy and the first two years postpartum. Methods: We analyzed prospective data from the Avon Longitudinal Study of Parents and Children (ALSPAC), a population-based cohort from the UK. Alcohol and cigarette use were assessed across all three trimesters and modeled as longitudinal patterns (abstained, persistent, intermittent, discontinued). Maternal depressive and anxiety symptoms were measured from the second trimester through 21 months postpartum using the Crown-Crisp Experiential Index. Results: Persistent alcohol use was associated with higher depressive and anxiety symptoms and slower symptom declines over time, while women with intermittent or discontinued use had symptom profiles similar to abstainers. By contrast, persistent, intermittent, and quitting smoking patterns were associated with higher symptom levels overall, with persistent smoking additionally associated with steeper declines in symptoms over time. Conclusion: Our findings highlight the importance of considering the persistence and cessation of substance use during pregnancy in the context of maternal mental health, pointing to patterns of persistent substance use as a potential target to inform screening and early intervention for women at higher risk for perinatal psychological distress. Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Ethical approval for the study was obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics Committees. Informed consent for the use of data collected via questionnaires and clinics was obtained from participants following the recommendations of the ALSPAC Ethics and Law Committee. Study participation was voluntary, and participants provided informed consent for the intended use of all data collected during collection sweeps. The completion of a questionnaire, either on paper or online, was considered to be written consent from participants to use their data for research purposes. Data in this study were fully anonymized, and participants can contact the study team at any time to retrospectively withdraw consent for their data to be used. Secondary analyses of these data were approved with oversight by the Mass General Brigham Institutional Review Boards (Protocol 2023P000011). I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability The informed consent obtained from ALSPAC participants does not allow the data to be made available through any third-party maintained public repository. All data are available by request from the ALSPAC Executive Committee for researchers who meet the criteria for access to confidential data (https://bristol.ac.uk/alspac/researchers/access). The ALSPAC study website contains details of all available data (https://www.bristol.ac.uk/alspac/researchers/our-data/). Funder Information Declared National Institutes of Health, https://ror.org/01cwqze88 , R21AA030640 , R01DA050700 MQ Foundation , MQF22\9 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Back to top Previous Next Posted October 05, 2026. Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Patterns of substance use during pregnancy are differentially associated with maternal mental health across the perinatal period Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Patterns of substance use during pregnancy are differentially associated with maternal mental health across the perinatal period Kimberly N Palmer , Ka Ying Toby Law , Suena H Massey , Alexandre A Lussier medRxiv 2026.10.01.26364530; doi: https://doi.org/10.64898/2026.10.01.26364530 Share This Article: Copy Citation Tools Patterns of substance use during pregnancy are differentially associated with maternal mental health across the perinatal period Kimberly N Palmer , Ka Ying Toby Law , Suena H Massey , Alexandre A Lussier medRxiv 2026.10.01.26364530; doi: https://doi.org/10.64898/2026.10.01.26364530 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Addiction Medicine (625) Allergy and Immunology (913) Anesthesia (340) Cardiovascular Medicine (4883) Dentistry and Oral Medicine (484) Dermatology (421) Emergency Medicine (658) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1641) Epidemiology (16056) Forensic Medicine (34) Gastroenterology (1218) Genetic and Genomic Medicine (7123) Geriatric Medicine (736) Health Economics (1072) Health Informatics (5117) Health Policy (1447) Health Systems and Quality Improvement (1792) Hematology (589) HIV/AIDS (1355) Infectious Diseases (except HIV/AIDS) (16352) Intensive Care and Critical Care Medicine (1183) Medical Education (677) Medical Ethics (156) Nephrology (729) Neurology (7377) Nursing (370) Nutrition (1101) Obstetrics and Gynecology (1261) Occupational and Environmental Health (1010) Oncology (3655) Ophthalmology (1066) Orthopedics (399) Otolaryngology (459) Pain Medicine (483) Palliative Medicine (142) Pathology (711) Pediatrics (1821) Pharmacology and Therapeutics (741) Primary Care Research (775) Psychiatry and Clinical Psychology (5979) Public and Global Health (9829) Radiology and Imaging (2461) Rehabilitation Medicine and Physical Therapy (1478) Respiratory Medicine (1256) Rheumatology (648) Sexual and Reproductive Health (785) Sports Medicine (588) Surgery (786) Toxicology (107) Transplantation (310) Urology (297)
## Related Clinical Research

- [Global study finds women report more pain than men across 11 body sites](https://medichelpline.com/clinical-feed/medical-news-today-0-women-consistently-experience-more-pain-than-men-across-11-body-parts.md)
- [Multidose Psilocybin for Obsessive-Compulsive Disorder: Open-Label Randomized Trial Results](https://medichelpline.com/clinical-feed/medrxiv-10-an-open-label-multidose-psilocybin-intervention-for-obsessive-compulsive.md)
- [Men with Multiple Long-Term Conditions and Disability in the Game of Stones Weight Management Trial](https://medichelpline.com/clinical-feed/bmj-open-2-mens-experiences-of-multiple-long-term-conditions-and-or-disability-in-the-uk.md)
- [Multimorbidity and mental health in older Chinese adults: how family and social support modify risk](https://medichelpline.com/clinical-feed/plos-one-23-chronic-disease-multimorbidity-and-mental-health-among-older-adults-in-china.md)
- [End-of-life symptom prevalence and drivers among hospital decedents in South Korea](https://medichelpline.com/clinical-feed/plos-one-3-prevalence-and-influencing-factors-of-end-of-life-symptoms-among-hospital.md)

## Navigation
- [← Back to General Feed](https://medichelpline.com/clinical-feed/general.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.